Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Barriers and facilitators to reducing paracetamol use in low back pain: A qualitative study (2023) |
Auteurs : | Thomas Patterson ; Paula R. Beckenkamp ; Justin Turner ; Danijela Gnjidic ; Barbara Mintzes ; Carol Bennett ; Lisa Bywaters ; Ornella Clavisi ; Melissa Baysari ; Manuela Ferreira ; Paulo Ferreira |
Type de document : | Article |
Dans : | Musculoskeletal Science and Practice (Vol. 67, October 2023) |
Article en page(s) : | 102856 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Education |
Mots-clés: | Analgesics ; Barriers ; Consumer ; Deprescribing ; Facilitators ; Low back pain ; Paracetamol ; Qualitative |
Résumé : | Background Paracetamol is widely used for low back pain (LBP), but research questions its efficacy and safety. Patient education booklets have been explored for promoting deprescribing, but barriers and facilitators specific to LBP deprescribing remain unexamined. Objective To identify contextual factors facilitating and obstructing successful deprescribing of paracetamol for LBP after receiving an educational booklet. Study design This study is part of an uncontrolled cohort feasibility study (CEASE NOW) in the community, recruiting from Musculoskeletal Australia and painaustralia. Patient sample Twenty-four participants with acute, sub-acute, or chronic LBP, self-reporting paracetamol consumption, were included. Methods Thematic content analysis was used to analyze qualitative data on barriers and facilitators. Data were categorized by deprescribing outcomes: i) successful deprescribing, ii) attempted but failed, or iii) no attempt. Semi-structured telephone interviews were conducted within one week after each participant completed the one-month follow-up. Results Successful deprescribing was facilitated by supportive healthcare professionals, willingness, high self-efficacy, fear of future illness, and diverse strategies for deprescribing plans. Barriers included unsupportive healthcare professionals and fear of flare-ups. Participants not attempting deprescribing believed it unnecessary, perceived it as effortful, unquestioningly trusted healthcare professionals, and lacked risk awareness. Conclusions Support from healthcare professionals, patient willingness, perceived necessity, risk awareness, effort, and varied strategies influence deprescribing outcomes for LBP patients using paracetamol. Addressing these factors is crucial when designing interventions to promote safe and effective deprescribing in LBP management. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S2468781223001418 |